Its empirical formula is C 17 H 18 FN 3 O 3 and its chemical structure is: We comply with the HONcode standard for trustworthy health information - Step 5: Write the expiration date of the re-constituted oral suspension on the bottle label.Reconstituted product may be stored below 30°C (86°F) for 14 days. CIPRO Tablets and Oral Suspension should be administered orally as described in the appropriate Dosage Guidelines tables.The determination of dosage and duration for any particular patient must take into consideration the severity and nature of the infection, the susceptibility of the causative microorganism, the integrity of the patient’s host-defense mechanisms, and the status of renal and hepatic function. Crystalluria has been reported with quinolones.Instruct the patient of the appropriate CIPRO administration CIPRO Oral Suspension is supplied in 5% (5 g ciprofloxacin in 100 mL) and 10% (10 g ciprofloxacin in 100 mL) strengths. CIPRO oral suspension is composed of two components (microcapsules and diluent) that must be combined prior to dispensing.The small bottle contains the microcapsules, the large bottle contains the diluent.Open both bottles. Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. No information is available on dosing adjustments necessary for pediatric patients with moderate to severe renal insufficiency (that is, creatinine clearance of < 50 mL/min/1.73mAdminister CIPRO at least 2 hours before or 6 hours after magnesium/aluminum antacids; polymeric phosphate binders (for example, sevelamer, lanthanum carbonate) or sucralfate; VidexConcomitant administration of CIPRO with dairy products (like milk or yogurt) or calcium-fortified juices alone should be avoided since decreased absorption is possible; however, CIPRO may be taken with a meal that contains these products.Assure adequate hydration of patients receiving CIPRO to prevent the formation of highly concentrated urine. It will not work for virus infections (such as common cold, flu).Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. -In pregnant women, IV ciprofloxacin is a preferred agent for treatment and oral ciprofloxacin is a preferred agent for postexposure prophylaxis; postexposure prophylaxis is only recommended when benefits outweigh risks. A single dose of ciprofloxacin may be used for the prevention of a secondary case of meningococcal meningitis. Protect from freezing.No additions should be made to the mixed final ciprofloxacin suspension. This antibiotic treats only bacterial infections. Pharmacokinetics of ciprofloxacin were linear over the dose range up to 400 mg administered intravenously. Dosage guidelines for use in patients with renal impairment are shown in Table 4.When only the serum creatinine concentration is known, the following formulas may be used to estimate creatinine clearance:The serum creatinine should represent a steady state of renal function.In patients with severe infections and severe renal impairment, a unit dose of 750 mg may be administered at the intervals noted above. Administer CIPRO for Oral Suspension using the co-packaged graduated spoon (maximum 750 mg per dose; not to be exceeded even in patients weighing more than 51 kg)Ciprofloxacin is eliminated primarily by renal excretion; however, the drug is also metabolized and partially cleared through the biliary system of the liver and through the intestine. These alternative pathways of drug elimination appear to compensate for the reduced renal excretion in patients with renal impairment. ... -Preoperative dose: 400 mg IV once, starting within 120 minutes before surgical incision Select one or more newsletters to continue. CIPRO oral suspension is composed of two components (microcapsules and diluent) that must be combined prior to dispensing. Manufacturer advises caution. 6 to 10 mg/kg/dose IV every 8 hours (Max: 400 mg/dose) for 10 to 21 days (mean duration of treatment in studies was 11 days); may switch to oral therapy as appropriate. CIPRO should be administered as described in Table 3. Child-proof cap: Press down according to instructions on the cap while turning to the left.Pour the microcapsules completely into the larger bottle of diluent. Ciprofloxacin is not considered a drug of first choice due to increased incidence of adverse reactions. Administer CIPRO for Oral Suspension using the co-packaged graduated spoon Patients whose therapy is started with CIPRO IV may be switched to CIPRO Tablets or Oral Suspension when clinically indicated at the discretion of the physician (Table 2) Dosing and initial route of therapy (that is, IV or oral) for cUTI or pyelonephritis should be determined by the severity of the infection. CIPRO IV (ciprofloxacin) is a synthetic antimicrobial agent for intravenous (IV) administration.